A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants.
Clinical trial NCT03436316 · COMPLETED
Trial details
- NCT number
- NCT03436316
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-26
- Primary completion
- 2019-07-29
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.